Curcuvail®
Curcumin is a yellow pigment found primarily in turmeric. Curcumin has been researched in the last 30 years over 6000 published papers for its role as an anti-inflammatory, immunomodulator anti- carcinogenic, antimicrobial and cardioprotector.
Key Benefits
Anti Inflammatory and Immunomodulator
Improves Joint and Muscle Health
Boosts Cognitive Function
Supports Cardiovascular Function
Supports Healthy Mood Balance
Find it in
Where and How
Product Specifications
Standardised to 35% Curcuminoids+
The name Curcumin or Curcuminoids is used to indicate for all the 3 polyphenols found in turmeric, Curcumin, Demethoxy Curcumin and Bis-demethoxy Curcumin. So if our product contains 1000 mg of Curcuvail, it would have 350 mg of curcuminoids.
Extracted from Turmeric+
Curcumin is extracted to produce supplements that have a much higher potency than turmeric. However, curcumin is absorbed poorly during digestion, so a myriad of different formulations have been created to improve its bioavailability.
Parts Used : Rhizome
- Cultivated in : India
- Extracted in : India
Our rationale
Why did we choose this brand
Special dispersion technology that leads to quicker absorbtion in the body and enhanced bioavailability
Does not need any bioavailability enhancer
Curcuvail is clinically evidenced to be 3X more absorbed in the blood and 9X more bioavailable than conventional 95% Curcuminoids' extracts
Curcuvail is clinically evidenced for its role in Immune balance, upper respiratory tract infections and joint health
Processed in GMP certified plant
Self affirmed Gras status
End to end traceability from field to the factory
Processed in low temperature to retain bioactive potency
Broad Spectrum of protection and benefits
Tested For
-
Pesticide Residue
-
Residual Solvent
-
Heavy Metals
-
Yeast & Mold
-
Pathogens
Certified As
-
Non-Irradiated
-
Non-GMO
Clinical Studies
Bioavailability Study+
Bioavailability Study
In an open-label, balanced, randomised, crossover, relative study of 24 healthy adults under fasting conditions were given 500mg of Cucurmin 95% and 500mg of Curcuvail in capsule. The mean plasma concentration was measured after 5 hours showing 3X more absorption of Curcuvail and 9X more bioavailable.
Upper Respiratory Tract Infections+
Chronic Bronchitis Study
In a study conducted for 10 weeks on 40 subjects , patients were given 500 mg of Curcuvail twice a day or a placebo . At the end of the treatment, Curcuvail administered patients showed statistically significant improvement of symptoms such as coughing, mucus secretion, wheezing, low grade fever, chest discomfort, shortness of breath, cold and recurrence of respiratory infection. At the end of the treatment, Curcuvail administered patients' chest X-ray analysis showed significnat improvement of mucus clearance of bronchi.
Immune System+
Anti-inflammatory and Immuno-modulatory Effect
In a study conducted for 10 weeks on 40 subjects , patients were given 500 mg of Curcuvail twice a day or a placebo . Immunological parameters such as IgG, IgM and IgE showed marked improvement in comparison to placebo group.
BIBLIOGRAPHY
1. Clinical Study to Evaluate the Efficacy & Safety of Curcumin Capsule in Patient with Chronic Bronchitis Dr. Harisha S., Director ICBio Clinical Research Pvt Ltd., European Journal Of Pharmaceutical & Medical Research , 2019,6(12), 508-519
2. A Clinical Study to Evaluate the Efficacy & Safety of Curcuvail in Patient with Chronic Joint Pain (Rheumatoid Arthritis)
Dr. Harisha S., Director ICBio Clinical Research Pvt Ltd., European Journal Of Pharmaceutical & Medical Research , 2020,7(3), 288-299
3. Bioavailability of a Bioavailable Cucumin in Healthy Human Dr. Harisha S., Director ICBio Clinical Research Pvt Ltd., European Journal Of Pharmaceutical & Medical Research , 2019,6(4), 570-573
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device